BHVN Overview
Upcoming Projects (BHVN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BHVN)
-
Looking at the recent Phase 3 results on Scholar Rock's apitegromab for Spinal Muscular Atrophy
Tickers: SRRK, RHHBF, BHVN, BIIB
Executed On: Oct 10, 2024 at 03:00 PM EDT -
Discussing the use of myostatin inhibitors in SMA
Tickers: BHVN, SRRK, RHHBY
Executed On: Aug 20, 2024 at 11:00 AM EDT -
Examining the use of Nurtech in migraines and where AXS-07 could fit in if approved
Tickers: AXSM, BHVN, PFE
Executed On: Jul 22, 2022 at 11:00 AM EDT -
Discussing Biohaven’s Nurtec ODT in treating migraines - 2nd look
Ticker: BHVN
Executed On: Apr 21, 2022 at 01:30 PM EDT -
Discussing Biohaven’s Nurtec ODT in treating migraines
Ticker: BHVN
Executed On: Apr 11, 2022 at 08:00 PM EDT
Expired Projects (BHVN)
-
Discussing Biohaven's BHV-7000 for treating seizures
Ticker: BHVN
Execute By: May 31, 2023 -
Digging into Biohaven's BHV-0223 in treating ALS
Tickers: BHVN, CTLT
Execute By: Oct 04, 2019
Upcoming & Overdue Catalysts (BHVN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (BHVN)
-
Phase 2/3 data of Biohaven's (BHVN) TRORILUZOLE in Generalized anxiety disorder (GAD) due early-1Q 2020
Ticker: BHVN
Occurred on: Feb 10, 2020 -
Biohaven's (BHVN) BHV-0223 in Amyotrophic lateral sclerosis PDUFA Estimate due July 25, 2019
Ticker: BHVN
Occurred on: Jul 20, 2019 -
Biohaven's Rimegepant in treating Migraine Phase 3 top-line data due 1Q 2018
Ticker: BHVN
Occurred on: Mar 01, 2018 -
Biohaven commences clinical testing of BHV-4157
Tickers: BHVN, Portage
Occurred on: Jul 21, 2016 -
Biohaven Announces Expedited Development Path for BHV-0223 Following Successful pre-IND Interaction with FDA
Ticker: BHVN
Occurred on: Feb 25, 2016
Strategic Initiatives (BHVN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
